Substitute House Bill No. 6855, also known as Public Act No. 25-101, establishes new regulations for the sale of hemp flower and the operation of nonresident pharmacies in Connecticut. Effective October 1, 2025, the bill permits individuals without cannabis establishment licenses to sell hemp flower under specific conditions, including in-person assistance and age verification for purchasers. It also revises definitions related to cannabis and hemp to align with existing statutes. For nonresident pharmacies, starting January 1, 2026, the bill requires registration with the state and annual operational reports, while streamlining language by replacing phrases like "A nonresident pharmacy shall file" with "File." Additionally, it mandates compliance with sterile compounding standards and inspection reports from government agencies or qualified third parties, enhancing oversight of pharmacies delivering medications in Connecticut.

The bill further modifies the classification of marijuana under controlled substances regulations, designating it as a schedule II controlled substance and allowing the Commissioner of Consumer Protection to classify new substances. It introduces provisions for the palliative use of marijuana, allowing healthcare providers to issue certifications for qualifying patients and protecting them from legal repercussions. Licensed dispensaries can also issue temporary certifications for up to ninety days, with specific documentation requirements. The bill updates definitions, repeals certain restrictions, and introduces new regulations for cannabis establishments, including license nonrenewal and reinstatement processes. Overall, the bill aims to enhance regulatory frameworks for both hemp and cannabis products while ensuring consumer protection and compliance within the industry.

Statutes affected:
Raised Bill: 20-627
GL Joint Favorable Substitute: 20-627
File No. 618: 20-627
Public Act No. 25-101: 20-627